Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × Tyrosine Kinase Inhibitors × Clear all

NCT05824481 2026-03-10

Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer

Phase 2 Active not recruiting

Endometrial Neoplasms